01 15VERTEX PHARMS INC
01 1510081621
01 15Blank
01 15Y
01 152031-03-25
Patent Expiration Date : 2031-03-25
ELEXACAFTOR, IVACAFTOR, TEZACAFTOR; IVACAFTOR
US Patent Number : 10081621
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 217660
Patent Use Code : U-3600
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2031-03-25
Patent Expiration Date : 2031-03-25
ELEXACAFTOR, IVACAFTOR, TEZACAFTOR; IVACAFTOR
US Patent Number : 10081621
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 217660
Patent Use Code : U-4065
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2031-03-25
Patent Expiration Date : 2031-03-25
ELEXACAFTOR, IVACAFTOR, TEZACAFTOR; IVACAFTOR
US Patent Number : 10081621
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 212273
Patent Use Code : U-3032
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2031-03-25
Patent Expiration Date : 2031-03-25
DEUTIVACAFTOR; TEZACAFTOR; VANZACAFTOR CALCIUM
US Patent Number : 10081621
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 218730
Patent Use Code : U-4087
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2031-03-25
Patent Expiration Date : 2031-03-25
ELEXACAFTOR, IVACAFTOR, TEZACAFTOR; IVACAFTOR
US Patent Number : 10081621
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 217660
Patent Use Code : U-3600
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2031-03-25
Patent Expiration Date : 2031-03-25
ELEXACAFTOR, IVACAFTOR, TEZACAFTOR; IVACAFTOR
US Patent Number : 10081621
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 212273
Patent Use Code : U-3157
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2031-03-25
Patent Expiration Date : 2031-03-25
ELEXACAFTOR, IVACAFTOR, TEZACAFTOR; IVACAFTOR
US Patent Number : 10081621
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 212273
Patent Use Code : U-4075
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2031-03-25
Patent Expiration Date : 2031-03-25
ELEXACAFTOR, IVACAFTOR, TEZACAFTOR; IVACAFTOR
US Patent Number : 10081621
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 217660
Patent Use Code : U-4065
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2031-03-25
Patent Expiration Date : 2031-03-25
IVACAFTOR; IVACAFTOR, TEZACAFTOR
US Patent Number : 10081621
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 210491
Patent Use Code : U-3024
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2031-03-25
Patent Expiration Date : 2031-03-25
IVACAFTOR; IVACAFTOR, TEZACAFTOR
US Patent Number : 10081621
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 210491
Patent Use Code : U-3025
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2031-03-25
